Epstein AL - Search Results

1

Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas.

Turner RR, Layfield LJ, Bishop PC, Epstein AL, Parker JW. Turner RR, et al. Among authors: epstein al. Arch Pathol Lab Med. 1989 Aug;113(8):907-11. Arch Pathol Lab Med. 1989. PMID: 2569301

2

Flow cytometric DNA and nuclear antigen content in astrocytic neoplasms.

Fitzgibbons PL, Turner RR, Appley AJ, Bishop PC, Nichols PW, Epstein AL, Apuzzo ML, Chandrasoma PT. Fitzgibbons PL, et al. Among authors: epstein al. Am J Clin Pathol. 1988 May;89(5):640-4. doi: 10.1093/ajcp/89.5.640. Am J Clin Pathol. 1988. PMID: 2895977

3

Immunohistochemical characterization of two new monoclonal antibodies (LN-4, LN-5) reactive with human macrophage subsets and derived malignancies in B5-fixed, paraffin-embedded tissues.

Bhoopat L, Turner RR, Stathopoulos E, Meyer PR, Taylor CR, Marder RJ, Epstein AL. Bhoopat L, et al. Among authors: epstein al. Blood. 1988 Apr;71(4):1079-85. Blood. 1988. PMID: 3281719 Free article.

4

Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.

Epstein AL, Marder RJ, Winter JN, Stathopoulos E, Chen FM, Parker JW, Taylor CR. Epstein AL, et al. Cancer Res. 1987 Feb 1;47(3):830-40. Cancer Res. 1987. PMID: 3542194

5

Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.

Imam A, Stathopoulos E, Holland SL, Epstein AL, Taylor CR. Imam A, et al. Among authors: epstein al. Cancer Res. 1990 Mar 1;50(5):1650-7. Cancer Res. 1990. PMID: 1689214

6

Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in advanced gastric cancers.

Kimura H, Yonemura Y, Epstein AL. Kimura H, et al. Among authors: epstein al. Cancer. 1991 Nov 15;68(10):2175-80. doi: 10.1002/1097-0142(19911115)68:10<2175::aid-cncr2820681015>3.0.co;2-n. Cancer. 1991. PMID: 1913456 Free article.

7

Heterogeneity of phenotypic expression in normal and neoplastic B-cell proliferations detected by monoclonal antibodies LN-1 and DLC-48.

Marder RJ, Winter J, Epstein A. Marder RJ, et al. Am J Clin Pathol. 1988 Aug;90(2):149-55. doi: 10.1093/ajcp/90.2.149. Am J Clin Pathol. 1988. PMID: 3260742

8

Generation of rituximab polymer may cause hyper-cross-linking-induced apoptosis in non-Hodgkin's lymphomas.

Zhang N, Khawli LA, Hu P, Epstein AL. Zhang N, et al. Among authors: epstein al. Clin Cancer Res. 2005 Aug 15;11(16):5971-80. doi: 10.1158/1078-0432.CCR-05-0554. Clin Cancer Res. 2005. PMID: 16115941

9

Lym-1-induced apoptosis of non-Hodgkin's lymphomas produces regression of transplanted tumors.

Zhang N, Khawli LA, Hu P, Epstein AL. Zhang N, et al. Among authors: epstein al. Cancer Biother Radiopharm. 2007 Jun;22(3):342-56. doi: 10.1089/cbr.2007.359.A. Cancer Biother Radiopharm. 2007. PMID: 17651040

10

Adaptable antibody Nanoworms designed for non-Hodgkin lymphoma.

Lee C, Peddi S, Anderson C, Su H, Cui H, Epstein AL, MacKay JA. Lee C, et al. Among authors: epstein al. Biomaterials. 2020 Dec;262:120338. doi: 10.1016/j.biomaterials.2020.120338. Epub 2020 Aug 31. Biomaterials. 2020. PMID: 32916604 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters